Skip to content

FLS

Current
Price
$76.74
Discount category
Close to intrinsic value
Intrinsic value source
AI estimate
Next earnings
Jan 28, 2027
Next earnings is estimate
Yes
Company name
Flowserve
Sector
Flow control equipment: pumps, valves and seals
About
Flowserve Corporation (FLS) is based in Irving, Texas. It makes and services pumps, valves, seals and automation products that move and control fluids in oil and gas, chemical, power, water and general industrial plants. It has two segments, the Flowserve Pumps Division and the Flow Control Division. In 2025, sales were $4,729.3 million, and aftermarket sales gave about 53% of total sales. The chemical industry gave about 19% of 2025 bookings and power generation about 14%. Flowserve has about 16,000 employees and works in more than 48 countries. Its common stock trades on the NYSE in US dollars. Flowserve files 10-K and 10-Q reports.
Thesis
The price of Flowserve depends on whether it can turn its record backlog into sales while the Middle East conflict delays work. The backlog rose 20% to $3,471.8 million at September 30, 2026, and the adjusted operating margin rose to 16.5% in Q3, but Flowserve lowered its 2026 organic sales guidance in July and again in October because customers in the Middle East delayed activity. Changes of the CFO and other managers in 2026 and pressure from Starboard Value add doubt. For the price to rise toward the AI estimate, three things must be true. Flowserve must reach its 2026 guidance of adjusted EPS of $4.10 to $4.20. Sales must grow again in 2027 as the backlog and the Trillium valves business add revenue. The adjusted operating margin must keep rising toward the 2030 target of about 20%. The Q4 2026 report, expected in late January 2027 with the 2027 guidance, is the next test, and the 2027 results show if the margin plan works.
Valuation
The intrinsic value for Flowserve is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of Flowserve with the SEC. The method is a multiple of 2027 adjusted EBITDA, less net debt and the noncontrolling interests, divided by the diluted shares. The Q4 2025 release (8-K, February 5, 2026) gives 2025 sales of $4,729.3 million. The Q3 2026 release (8-K, October 28, 2026) gives sales of $3,475.2 million for nine months with an adjusted operating margin of 15.6%, and backlog of $3,471.8 million. It guides 2026 total sales growth of 2% to 3% and adjusted EPS of $4.10 to $4.20. The Form 10-Q for the quarter ended September 30, 2026 gives depreciation of $61.5 million and amortization of $24.8 million for nine months. The estimate takes 2026 adjusted EBITDA as about $870 million, from the guided sales, the adjusted operating margin of the first nine months and this rate of depreciation and amortization, which is an assumption. The 10-Q gives debt and finance lease obligations of $2,056.7 million, cash of $742.1 million and noncontrolling interests of $71.9 million. The estimate counts the noncontrolling interests at their book value as debt, which is an assumption, so net debt with these items is $1,386.4 million. The cover of the 10-Q gives 126,806,088 shares at October 20, 2026, and the Q3 release gives 0.80 million dilutive shares (diluted 127,962 thousand less basic 127,164 thousand), so the estimate uses 127.60 million shares. The 2027 adjusted EBITDA and the multiples are assumptions. The low case assumes $880 million, because the Middle East conflict and slower project work delay sales, at 10 times. It gives $58.10 per share. The base case assumes $960 million, from a full year of Trillium Flow Technologies' valves division and deliveries of the backlog, at 12 times. It gives $79.41 per share. The high case assumes $1,040 million, from growth in nuclear and power work and margins on the path to the 2030 target, at 14 times. It gives $103.24 per share. The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $80.04 per share. Flowserve pumps, valves and seals are installed in refineries, chemical plants and power plants, and aftermarket sales gave about 53% of 2025 sales (Form 10-K), which supports its returns, but large competitors sell similar products, and new equipment orders follow the capital spending cycles of its customers. As of Nov 14, 2026.
Risks
The armed conflict with Iran slows activity in the Middle East. Sales in the Middle East and Africa fell to $170.9 million in Q3 2026 from $198.7 million a year before, and longer delays can reduce 2027 sales. Orders for new pumps and valves depend on capital spending in oil and gas, chemicals and power. Lower energy prices or weaker industry can delay projects. Debt rose to $2,056.7 million at September 30, 2026 after the Trillium valves purchase. If the business earns less than planned, the purchase can reduce returns. Flowserve changed its CFO, its Chief Accounting Officer and the President of its pumps division in 2026, and Starboard Value pushes for changes. New leaders or outside pressure can change the plan. Tariffs, currency controls in Argentina and changes in exchange rates can reduce margins and cash.
Balance sheet
Cash: $742M Debt: $2.1B Net debt: $1.3B Undrawn credit line: $827M, to April 2031 Debt due within 12 months: $9.9M Last debt due: 2036 At September 30, 2026, Flowserve had cash and cash equivalents of $742.1 million and debt and finance lease obligations of $2,056.7 million, of which $9.9 million was due within one year. The debt includes senior notes of $500 million each at 3.50% due 2030, 2.80% due 2032 and 5.70% due 2036, a $450 million term loan, and $90.0 million drawn on the $1,000 million revolving credit facility, both due April 15, 2031. After letters of credit, $827.0 million of the revolving credit facility was available. Total equity was $2,383.4 million, including noncontrolling interests of $71.9 million. As of Sep 30, 2026.
Checkpoints
Jan 28, 2027 (estimate): Q4 2026 results and 2027 guidance. Pending. Watch: Adjusted EPS for 2026 is within $4.10 to $4.20 and the 2027 guidance shows sales growth and a higher adjusted operating margin, and this passes; lower guidance fails. 2027 (estimate): 2027 results: backlog and margin. Pending. Watch: Sales grow from the backlog and the adjusted operating margin rises toward the 2030 target of about 20%, and this passes; flat sales or a lower margin fail.
Recent events
Oct 28, 2026: Flowserve reported Q3 2026 results. Bookings rose 14% to $1,383.5 million, with record aftermarket bookings of $727.7 million, and sales rose 5.4% to $1,237.8 million. The adjusted operating margin was 16.5%, EPS was $0.81 and adjusted EPS was $1.07. Backlog rose 20% to $3,471.8 million. Flowserve raised the low end of its 2026 adjusted EPS guidance to $4.10 to $4.20 and lowered its organic sales guidance to a decline of 2.5% to 1.5% because of the Middle East. Oct 26, 2026: The Board increased the remaining capacity of the share repurchase program to $500.0 million. Sep 14, 2026: Flowserve said that its CFO, Amy B. Schwetz, would leave on September 30, 2026 to join another public company. Brian Ezzell, its Vice President of FP&A, Treasurer and Investor Relations, became CFO on October 1, 2026. Aug 6, 2026: Flowserve sold its PMV Automation business for $34.6 million in cash and recorded a gain of $16.2 million. Jul 29, 2026: Flowserve reported Q2 2026 results. Bookings rose 26% to $1.35 billion, the adjusted operating margin was 15.3% and adjusted EPS was $0.95. Flowserve cut its 2026 organic sales guidance to a decline of about 1% because of the Middle East conflict. Jun 30, 2026: Flowserve completed the purchase of the valves division of Trillium Flow Technologies for $490 million in cash. The business makes engineered valves for nuclear and other power plants and industry. May 28, 2026: Flowserve answered a letter from the investor Starboard Value. It said that its adjusted operating margin rose by 860 basis points since 2022, and it confirmed its 2026 guidance and its 2030 targets. May 12, 2026: Flowserve sold $500 million of 5.70% senior notes due May 15, 2036 to pay for the Trillium valves purchase. Apr 15, 2026: Flowserve signed a new credit agreement with a $1,000 million revolving credit facility and a $450 million term loan, both due April 15, 2031. Feb 5, 2026: Flowserve reported 2025 results with sales of $4,729.3 million and bookings of $4.7 billion. It set 2030 targets of mid-single-digit organic sales growth per year, an adjusted operating margin of about 20% and double-digit adjusted EPS growth per year, and it announced the Trillium valves purchase.
See changes